Our Story
Pharma Biotech Consultants was founded in 2001 by Dr. Shyam S. Mohapatra, an internationally recognized scientist, inventor, and leader in pharmaceutical innovation. Created with a vision to bridge advanced biomedical research and real-world therapeutic impact, the firm brings together decades of scientific expertise, translational experience, and strategic insight to support organizations across the biotechnology and pharmaceutical landscape.
Dr. Mohapatra established Pharma Biotech Consultants to provide high-level guidance in drug development, translational research, nanomedicine, and technology commercialization. With a career spanning more than four decades in biotechnology, genetics, immunology, and nanotechnology, he brings a unique mix of scientific depth and industry-oriented leadership that has shaped the firm’s approach and values.
About Our Founder — Dr. Shyam S. Mohapatra:
Dr. Shyam Mohapatra is a Distinguished Health Professor, Associate Dean, and Director of the Center for Research & Education in Nanobioengineering at the University of South Florida (USF). He is widely recognized for his pioneering work in nanomedicine — including nanoscale therapeutics, molecular diagnostics, gene therapy platforms, drug-delivery technologies, and innovative treatments for cancer, asthma, viral infections, traumatic brain injury, and other complex diseases.
A Legacy of Innovation and Scientific Leadership:
240+ peer-reviewed scientific publications advancing molecular medicine, drug delivery, and translational biotechnology
40+ U.S. and international patents, including breakthrough nanoscale biomedical technologies
Founder of TransGenex Nanobiotech, Inc. (TGN) — a biotechnology company commercializing inventions from his laboratory
Fellow of the National Academy of Inventors (NAI)
Fellow of the American Institute for Medical and Biological Engineering (AIMBE)
Inductee, Florida Inventors Hall of Fame (2014) for contributions to nanotechnology and translational health innovation
Senior Research Career Scientist within the Veterans Health Administration
Dr. Mohapatra also founded USF’s nationally recognized Master’s Program in Pharmaceutical Nanotechnology, helping train the next generation of scientists and innovators.
His work demonstrates a lifelong dedication to transforming scientific discoveries into practical, life-changing therapeutic solutions — a philosophy that guides Pharma Biotech Consultants today.
What We Do:
Pharma Biotech Consultants provides strategic and scientific guidance tailored to the needs of biotechnology companies, pharmaceutical developers, medical technology innovators, academic research groups, and translational-medicine teams.
Our core capabilities include:
Strategic R&D Guidance
Helping organizations design strong research pathways, evaluate scientific feasibility, and align discovery with regulatory and commercial requirements.
• Translational Medicine & Nanotechnology Expertise
Offering highly specialized insight into nanomedicine, advanced drug delivery, cell-based technologies, RNA/DNA therapeutics, and emerging biotechnology platforms.
• Patent & Technology Commercialization Support
Providing guidance on intellectual property positioning, technology transfer, licensing, and early-stage commercialization strategies.
Scientific & Advisory Consulting
Supporting biotechnology ventures, research institutions, and clinical innovators with expert-level scientific direction, project evaluation, and innovation roadmap planning.
Our Mission:
Our mission is to accelerate meaningful biomedical innovation by combining scientific rigor, strategic clarity, and industry experience. We exist to help innovators transform bold ideas into validated technologies, viable products, and impactful therapies.
Our Vision:
To be a trusted partner for organizations advancing the future of biotechnology — enabling breakthroughs that improve human health, strengthen scientific discovery, and bring transformative therapies to the world.
Our Values:
Scientific Integrity— Evidence-based guidance grounded in decades of research excellence
Innovation — Support for ideas that challenge the boundaries of medicine
Collaboration— Strong partnerships across academia, industry, and government
Impact — Focus on real-world solutions that improve patient lives